Compounds > buthionine sulfoximine
Page last updated: 2024-08-22

buthionine sulfoximine and sirolimus

buthionine sulfoximine has been researched along with sirolimus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, A; Palakurthi, S; Vangara, KK; Yellepeddi, VK1
Cederbaum, AI; Wu, D1
Aronica, E; Borkowska, J; Grajkowska, W; Iyer, AM; Jaworski, J; Jozwiak, S; Kotulska, K; Kwiatkowski, DJ; Liszewska, E; Macias, M; Malik, AR; Parobczak, K; Perycz, M; Pietruszka, P; Skalecka, A; Swiech, LJ; Tyburczy, ME; Urbanska, M; Zarebska, MM1

Other Studies

3 other study(ies) available for buthionine sulfoximine and sirolimus

ArticleYear
Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells.
    Anticancer research, 2012, Volume: 32, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Cell Line, Tumor; CHO Cells; Cisplatin; Colchicine; Cricetinae; Cricetulus; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Isoflavones; Mass Spectrometry; Ovarian Neoplasms; Sirolimus; Trientine

2012
Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK.
    Redox biology, 2013, Volume: 1

    Topics: Adenine; Arachidonic Acid; Autophagy; Autophagy-Related Protein 7; Buthionine Sulfoximine; Carbon Tetrachloride; Cytochrome P-450 CYP2E1; Hep G2 Cells; Humans; MAP Kinase Signaling System; Mitochondria; Oxidative Stress; Sirolimus; Ubiquitin-Activating Enzymes

2013
Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.
    Acta neuropathologica communications, 2015, Jul-30, Volume: 3

    Topics: Adolescent; Animals; Brain; Buthionine Sulfoximine; Cell Proliferation; Child; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Green Fluorescent Proteins; Humans; Immunosuppressive Agents; Male; Neurons; RNA, Small Interfering; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Young Adult

2015